The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 4.15%.However, over the last six months, we can see a weaker performance of 8.89%. Over the last 30 days, the price of AZN has fallen by 5.98%. And in the last five days, it has surged by 2.06%.
Astrazeneca plc ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $76.56 on 04/25/23 and the lowest value was $60.47 on 02/12/24.
52-week price history of AZN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Astrazeneca plc ADR’s current trading price is -8.38% away from its 52-week high, while its distance from the 52-week low is 16.00%. The stock’s price range during this period has varied between$60.47 and $76.56. The Astrazeneca plc ADR’s shares, which operate in the Healthcare, saw a trading volume of around 1.76 million for the day, a figure considerably lower than their average daily volume of 6.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Astrazeneca plc ADR (AZN) has experienced a quarterly rise of 4.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 217.48B and boasts a workforce of 89900 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 66.29, with a change in price of +6.45. Similarly, Astrazeneca plc ADR recorded 5,902,514 in trading volume during the last 100 days, posting a change of +10.13%.
AZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.59.
AZN Stock Stochastic Average
Astrazeneca plc ADR’s raw stochastic average for the past 50 days is presently 98.37%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 96.45%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 73.81% and 67.37%, respectively.
